Is dipeptidylpeptidase IV the missing link in angiotensin-converting enzyme inhibitor--induced angioedema?
Grouzmann
Eric
E
Buclin
Thierry
T
D000799:Angioedema / Q000139:chemically induced* / Q000201:enzymology*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D001920:Bradykinin / Q000378:metabolism; D018819:Dipeptidyl Peptidase 4 / Q000378:metabolism*; D054873:Dipeptidyl-Peptidase IV Inhibitors; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D015260:Neprilysin / Q000378:metabolism; D007703:Peptidyl-Dipeptidase A / Q000378:metabolism; D013373:Substance P / Q000378:metabolism
D000806:Angiotensin-Converting Enzyme Inhibitors; D054873:Dipeptidyl-Peptidase IV Inhibitors; D004791:Enzyme Inhibitors; D013373:Substance P; D018819:Dipeptidyl Peptidase 4; D007703:Peptidyl-Dipeptidase A; D015260:Neprilysin; D001920:Bradykinin